Northern Trust
MRVI icon

Northern Trust’s Maravai LifeSciences MRVI Stock Holding History

Northern Trust’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.24M Sell
1,000,360
-110,554
-10% -$477K ﹤0.01% 2496
2026
Q1 		$3.14M Buy
1,110,914
+230,053
+26% +$780K ﹤0.01% 2715
2025
Q4 		$2.86M Sell
880,861
-45,826
-5% -$154K ﹤0.01% 2787
2025
Q3 		$2.66M Sell
926,687
-68,618
-7% -$175K ﹤0.01% 2873
2025
Q2 		$2.4M Sell
995,305
-94,153
-9% -$198K ﹤0.01% 2885
2025
Q1 		$2.41M Buy
1,089,458
+19,033
+2% +$75.2K ﹤0.01% 2822
2024
Q4 		$5.83M Buy
1,070,425
+53,474
+5% +$344K ﹤0.01% 2417
2024
Q3 		$8.45M Buy
1,016,951
+89,395
+10% +$773K ﹤0.01% 2161
2024
Q2 		$6.64M Sell
927,556
-23,756
-2% -$205K ﹤0.01% 2236
2024
Q1 		$8.25M Buy
951,312
+5,330
+0.6% +$36.1K ﹤0.01% 2169
2023
Q4 		$6.2M Sell
945,982
-44,222
-4% -$286K ﹤0.01% 2375
2023
Q3 		$9.9M Buy
990,204
+424,568
+75% +$4.66M ﹤0.01% 2014
2023
Q2 		$7.03M Sell
565,636
-255,251
-31% -$3.45M ﹤0.01% 2298
2023
Q1 		$11.5M Buy
820,887
+23,611
+3% +$339K ﹤0.01% 1920
2022
Q4 		$11.4M Buy
797,276
+276,055
+53% +$4.35M ﹤0.01% 1917
2022
Q3 		$13.3M Buy
521,221
+55,792
+12% +$1.4M ﹤0.01% 1780
2022
Q2 		$13.2M Sell
465,429
-21,578
-4% -$684K ﹤0.01% 1819
2022
Q1 		$17.2M Buy
487,007
+91
+0% +$3.05K ﹤0.01% 1780
2021
Q4 		$20.4M Buy
486,916
+18,840
+4% +$763K ﹤0.01% 1756
2021
Q3 		$23M Sell
468,076
-237,310
-34% -$11.6M ﹤0.01% 1699
2021
Q2 		$29.4M Buy
705,386
+359,390
+104% +$13.9M 0.01% 1610
2021
Q1 		$12.3M Buy
+345,996
New +$11.5M ﹤0.01% 2158

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Northern Trust's MRVI Position: Q2 2026 in Review

Northern Trust reduced its Maravai LifeSciences (MRVI) stake by 10% in Q2 2026, selling an estimated $477K and leaving 1,000,360 shares worth $6.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2496.

Northern Trust first reported a position in MRVI in Q1 2021 and has held it in 22 quarters since. The position peaked at $29.4M in Q2 2021. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Northern Trust held 1,000,360 shares of Maravai LifeSciences worth $6.24M as of Q2 2026.
  • Northern Trust sold 110,554 Maravai LifeSciences shares in Q2 2026, an estimated $477K.
  • Maravai LifeSciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #2496 holding.
  • Northern Trust first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 22 quarters since.
  • Northern Trust's Maravai LifeSciences position peaked at $29.4M in Q2 2021.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.